ADDRESSING A MANUFACTURING BOTTLENECK IN CAR-T THERAPY: SCALABLE PRODUCTION OF TRANSFECTION-GRADE PLASMID DNA FOR CAR-T VECTOR MANUFACTURING
Main Article Content
Authors
Abstract
The rapid advancing of cell and gene therapy has increased the demand for plasmid DNA used in viral vector manufacturing. The production of transfection-grade plasmid DNA remains a critical bottleneck, particularly for academic and emerging manufacturing facilities, due to the high cost and limited scalability of existing purification technologies. The aim of this study was to develop a practical and cost-effective approach for producing transfection-grade plasmid DNA suitable for lentiviral vector manufacturing.
The described acidic phenol extraction method was evaluated using plasmids commonly employed in lentiviral packaging systems and compared with a reference method, CsCl density gradient ultracentrifugation. The resulting plasmid preparations showed efficient removal of genomic DNA and other impurities, including endotoxin – the acidic phenol method consistently reduced endotoxin levels to 1.4–3.8 EU/µg DNA. Moreover, the purified plasmid DNA was predominantly in the supercoiled (covalently closed circular) form. Functional validation in transfection assays confirmed that plasmids purified by the proposed method supported lentiviral vector production with efficiency comparable to the reference method, yielding titers exceeding 5×106 TU/mL, with no statistically significant differences in transduction efficiency between the groups.
These findings confirm that the acidic phenol extraction method is a simple, scalable, and economical approach for isolating transfection-grade plasmid DNA for lentiviral vector production. The method represents a practical alternative to ultracentrifugation-based purification and may facilitate broader use of cell and gene therapy by reducing dependence on specialized equipment and costly commercial kits.
Keywords
plasmid DNA, lentiviral vector, CAR-T therapy, gene therapy, transfection-grade DNA, plasmid purification, cell and gene therapy, bioprocessing
Article Details
References
Prather K.J., Sagar S., Murphy J., Chartrain M. Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production, and purification // Enzyme Microb. Technol. – 2003. – T.33. – № 7. – P.865–883. – DOI: 10.1016/S0141-0229(03)00205-9.
Prazeres D.M.F., Ferreira G.N.M., Monteiro G.A., Cooney C.L., Cabral J.M.S. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: Problems and bottlenecks // Trends Biotechnol. – 1999. – T.17. – № 4. – P.169–174. – DOI: 10.1016/S0167-7799(98)01291-8.
Urthaler J., Buchinger W., Necina R. Industrial Scale cGMP Purification of Pharmaceutical Grade Plasmid-DNA // Chem. Eng. Technol. – 2005. – T.28. – № 12. – P.1408–1420. – DOI: 10.1002/ceat.200500126.
Naldini L., Blömer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector // Science. – 1996. – T.272. – № 5259. – P.263–267. – DOI: 10.1126/science.272.5259.263.
Milone M.C., O'Doherty U. Clinical use of lentiviral vectors // Leukemia. – 2018. – T.32. – № 7. – P.1529–1541. – DOI: 10.1038/s41375-018-0106-0.
Zoon K.C. Points to Consider on Plasmid DNA Vaccines for Preventive Infectious Disease Indications // Federal Register. – 1996. – T.61. – № 250. – P.68269–68270.
World Health Organization. WHO Expert Committee on Biological Standardisation. Forty-seventh Report // WHO Technical Report Series. – 1998. – № 878. – Geneva: WHO.
Eon-Duval A., MacDuff R.H., Fisher C.A., Harris M.J., Brook C. Removal of RNA impurities by tangential flow filtration in an RNase-free plasmid DNA purification process // Anal. Biochem. – 2003. – T.316. – № 1. – P.66–73. – DOI: 10.1016/S0003-2697(03)00050-2.
Bakker N.A.M., Boer R.D., Marie C., et al. Small-scale GMP production of plasmid DNA using a simplified and fully disposable production method // Biotechnol. X. – 2019. – T.4. – P.100007. – DOI: 10.1016/j.btecx.2019.100007.
Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual. 3rd ed. – Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2000.
Sousa F., Matos T., Prazeres D.M.F., Queiroz J.A. Biomedical application of plasmid DNA in gene therapy: a new challenge for chromatography // Biotechnol. Genet. Eng. Rev. – 2010. – T.26. – P.83–116.
Sigma-Aldrich. Chromatographic Purification of Plasmid DNA (pDNA) for mRNA, Plasmid-based DNA Vaccines, and Viral Vector Applications // Technical Bulletin. – 2026. – Available at: URL (accessed: 08.06.2026).
Yu M., Yu M., Qian F. Purification of plasmid DNA using a novel two-stage chromatography process // J. Chromatogr. B. – 2024. – T.1250. – P.124381. – DOI: 10.1016/j.jchromb.2024.124381.
Astrea Bioseparations. Purification of Plasmid DNA for Cell and Gene Therapies: A Scalable Solution // White Paper. – 2023.
SignaGen Laboratories. CsCl Gradient Ultracentrifugation vs Column Based Plasmid Purification. – Available at: URL (accessed: 08.06.2026).
Radloff R., Bauer W., Vinograd J. A dye buoyant density method for the detection and isolation of closed circular duplex DNA: the closed circular DNA in HeLa cells // Proc. Natl. Acad. Sci. USA. – 1967. – T.57. – № 5. – P.1514–1521. – DOI: 10.1073/pnas.57.5.1514.
Grierson D. Isopycnic Centrifugation of DNA // In: Slater R.J. (Ed.). Experiments in Molecular Biology. – Totowa, NJ: Humana Press, 1986. – P.93–101. – DOI: 10.1007/978-1-60327-405-0_10.
Van Helden P.D., Hoal E.G. Plasmid preparation on Sephacryl S-1000 // Methods Mol. Biol. – 1988. – T.4. – P.69–74. – DOI: 10.1385/0-89603-127-6:69.
Zasloff M., Ginder G.D., Felsenfeld G. A new method for the purification and identification of covalently closed circular DNA molecules // Nucleic Acids Res. – 1978. – T.5. – № 4. – P.1139–1152. – DOI: 10.1093/nar/5.4.1139.
Fisher J.A., Favreau M.B. Plasmid purification by phenol extraction from guanidinium thiocyanate solution: development of an automated protocol // Anal. Biochem. – 1991. – T.194. – № 2. – P.309–315. – DOI: 10.1016/0003-2697(91)90234-K.
Wang Z., Rossman T.G. Large-scale supercoiled plasmid preparation by acidic phenol extraction // Biotechniques. – 1994. – T.16. – № 3. – P.460–463.
Rice A., Rooney M.T., Greenwood A.I., Cotten M.L., Wereszczynski J. Lipopolysaccharide simulations are sensitive to phosphate charge and ion parameterization // J. Chem. Theory Comput. – 2020. – T.16. – № 3. – P.1806–1815. – DOI: 10.1021/acs.jctc.9b00868.
Kado C.I., Liu S.T. Rapid procedure for detection and isolation of large and small plasmids // J. Bacteriol. – 1981. – T.145. – № 3. – P.1365–1373. – DOI: 10.1128/jb.145.3.1365-1373.1981.
Westphal O., Jann K. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure // Methods Carbohydr. Chem. – 1965. – T.5. – P.83–91.
Keyer V., Syzdykova L., Ingirbay B., Sedova E., Zauatbayeva G., Kulatay T., Shevtsov A., Shustov A.V. Non-industrial production of therapeutic lentiviral vectors: how to provide vectors to academic CAR-T // Biotechnol. Bioeng. – 2024. – T.121. – № 9. – P.3252–3268. – DOI: 10.1002/bit.28794.
Merten O.W., Hebben M., Bovolenta C. Production of lentiviral vectors // Mol. Ther. Methods Clin. Dev. – 2016. – T.3. – P.16017. – DOI: 10.1038/mtm.2016.17.
Cheng Y.H., Wu Y.J., Shih Y.C., Lin Y.Q., Chang Y.W., Wu Y.H., Hu E.W., Ku R.H., Wu C.M., Wu S.C., Yeh T.Y., Chang C.T. The Filterprep: a simple and efficient approach for high-yield, high-purity plasmid DNA purification // N. Biotechnol. – 2025. – DOI: 10.1016/j.nbt.2025.09.003.
Wang X., Zhao L., Wu X., Luo H., Wu D., Zhang M., Zhang J., Zeng Z. Development of a simplified and inexpensive RNA depletion method for plasmid DNA purification using size selection magnetic beads (SSMBs) // Genes Dis. – 2021. – T.8. – № 3. – P.298–306. – DOI: 10.1016/j.gendis.2020.04.006.